Shane A. Campbell serves as Senior Vice President and Chief Proprietary Segment Officer at West Pharmaceutical Services Inc., where he leads the company's proprietary products portfolio, driving innovation in advanced drug delivery systems, including self-injection platforms and specialty closures. With over 25 years of experience in the pharmaceutical and medical device industries, Campbell joined West in 2005 as Director of Marketing for the Proprietary Products group, quickly rising through the ranks due to his strategic vision and operational expertise. Prior to West, he held progressive leadership roles at BD (Becton, Dickinson and Company), focusing on injectable drug delivery technologies, and began his career as a process engineer at a leading contract manufacturer. Under Campbell's leadership, West's Proprietary Segment has achieved significant milestones, including the successful commercialization of the Crystal Zenith® polymer syringes and the VIAL2BAR® labeling solution, which have expanded market share in biologics and high-value injectables. He spearheaded a 40% revenue growth in the segment over the past five years through strategic partnerships with top biopharma companies and investments in R&D for next-generation auto-injectors. His efforts earned him the industry's recognition, including the Healthcare Businesswomen's Association Rising Star Award in 2018 and multiple internal innovation accolades. In his current role, Campbell oversees a global team of 500+ professionals across R&D, manufacturing, and commercial operations, ensuring alignment with West's commitment to quality and patient-centric solutions. A chemical engineer by training with an MBA from the Wharton School, he is a frequent speaker at industry conferences like PDA and ISPE, advocating for sustainable manufacturing and digital transformation in pharma packaging. Campbell's strategic foresight continues to position West as a leader in proprietary drug containment and delivery technologies.